NCT01227369View on ClinicalTrials.gov

Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment

CompletedOBSERVATIONAL
Enrollment

4,376

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Osteoporosis, Postmenopausal
Interventions
OTHER

OPSAT-Q

A linguistically validated Korean version of OPSAT-Q

Trial Locations (1)

137-701

GSK Investigational Site, Seoul

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY